3/26
10:27 am
blte
Belite Bio, Inc (NASDAQ: BLTE) had its "buy" rating re-affirmed by analysts at Benchmark Co.. They now have a $80.00 price target on the stock.
Low
Report
Belite Bio, Inc (NASDAQ: BLTE) had its "buy" rating re-affirmed by analysts at Benchmark Co.. They now have a $80.00 price target on the stock.
3/26
10:27 am
blte
Belite Bio, Inc (NASDAQ: BLTE) had its "buy" rating re-affirmed by analysts at Benchmark Co.. They now have a $80.00 price target on the stock.
Low
Report
Belite Bio, Inc (NASDAQ: BLTE) had its "buy" rating re-affirmed by analysts at Benchmark Co.. They now have a $80.00 price target on the stock.
3/26
10:21 am
blte
Rating for BLTE
Low
Report
Rating for BLTE
3/26
10:21 am
blte
Rating for BLTE
Low
Report
Rating for BLTE
3/18
09:19 am
blte
Belite Bio, Inc (NASDAQ: BLTE) had its "overweight" rating re-affirmed by analysts at Cantor Fitzgerald.
Low
Report
Belite Bio, Inc (NASDAQ: BLTE) had its "overweight" rating re-affirmed by analysts at Cantor Fitzgerald.
3/18
09:02 am
blte
Rating for BLTE
Low
Report
Rating for BLTE
3/18
08:06 am
blte
Belite Bio, Inc (NASDAQ: BLTE) had its "buy" rating re-affirmed by analysts at HC Wainwright. They now have a $100.00 price target on the stock.
Low
Report
Belite Bio, Inc (NASDAQ: BLTE) had its "buy" rating re-affirmed by analysts at HC Wainwright. They now have a $100.00 price target on the stock.
1/21
11:43 am
blte
Rating for BLTE
Low
Report
Rating for BLTE
1/21
11:43 am
blte
Rating for BLTE
Low
Report
Rating for BLTE